The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

By J. Haviland, J. Owen, J. Dewar, R. Agrawal, J. Barrett, P.J. Barrett-Lee, H. Dobbs, P. Hopwood, P. Lawton, Brian Magee and 6 more. The Lancet Oncology, 2013

1,291 citations recorded by the source corpus.

Subfields: Cancer Research, Pathology and Forensic Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/c05de74b0df0d9da2a2e4d92a9badc998870a1dc

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Goldhirsch
2. A. Coates
3. R. Gelber
4. B. Thürlimann
5. H. Senn
6. M. Piccart-Gebhart
7. M. Gnant
8. Eric P. Winer

Citations in the corpus

• Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 (2015, background): “Hypofractionated shorter course radiotherapy has become accepted as a standard option [11, 12] offering increased patient convenience and reduced resource usage.”